This article is more than 5 years old. Information may no longer be current.

STAAR Surgical reports net loss in third quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical reported a net loss of $1.8 million, or $0.04 per share, in the third quarter, which is equal to its net loss in the third quarter of 2015, according to a company press release.

STAAR’s net sales were up 7% to $20.1 million, which was attributed to ICL revenue and unit growth, as well as IOL revenue growth. This was offset by lower sales of injector parts and a delay in orders from Canada for the EVO toric lens.

Operating expenses rose $1.8 million to $16.6 million compared with the same period last year, the release said, mostly due to quality system improvements and investments in international selling and marketing.